Why the study?
Does TIMI 3 flow before primary PCI improve clinical and angiographic outcomes in patients with STEMI?
Does TIMI 3 flow before primary PCI improve clinical and angiographic outcomes in patients with STEMI?
TIMI 3 patency before primary PCI, whether spontaneous or pharmacologically induced, is associated with better angiographic outcomes and a trend toward lower 90-day mortality.
No takes yet. Share an insight, caveat, or question.
Pre-PCI TIMI 3 patency was associated with lower 90-day mortality in STEMI; leaves open whether inducing flow improves outcomes.
Zeymer et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: